Related Experiment Videos
Cholesterol crystal embolization to liver, gallbladder, and pancreas
1Department of Internal Medicine, Wilhelmina Hospital, Assen, The Netherlands.
Digestive Diseases and Sciences
|September 1, 1996
Summary
Cholesterol crystal embolization (CCE) can cause liver necrosis, cholecystitis, and pancreatitis, particularly in elderly males with atherosclerosis. This condition often arises after vascular procedures or anticoagulant therapy.
Area of Science:
- Pathology
- Vascular Medicine
- Gastroenterology
Background:
- Cholesterol crystal embolization (CCE) is a rare complication.
- Atherosclerotic vascular disease is a common comorbidity.
Purpose of the Study:
- To investigate the clinical features of CCE affecting the liver, biliary system, and pancreas.
- To identify patient demographics and risk factors associated with CCE.
Main Methods:
- Retrospective analysis of 44 patients diagnosed with CCE.
- Data collected from the Dutch National Pathology Information System (DNPIS) between 1973 and 1994.
Main Results:
- CCE was found in the liver, gallbladder, pancreas, or combinations thereof.
- Manifestations included liver cell necrosis, cholecystitis, and pancreatitis.
- A history of atherosclerosis was present in all patients; provoking factors were noted in half.
Conclusions:
- CCE can lead to significant hepatic, biliary, and pancreatic pathology.
- Elderly males with atherosclerosis are particularly susceptible.
- CCE should be considered in the differential diagnosis of unexplained organ injury in at-risk patients.